| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price ...
Rockwell Medical (NASDAQ:RMTI) affirms FY2025 sales outlook from $65.000 million-$70.000 million to $65.000 million-$70.000 mil...
Rockwell Medical (NASDAQ:RMTI) reported quarterly sales of $15.927 million which missed the analyst consensus estimate of $16.2...